Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion description "[Over the last decade, inhibitors of PDE4 (a cAMP-specific family that negatively regulates the function of almost all pro-inflammatory and immune cells, and exerts widespread anti-inflammatory activity in animal models of asthma) have been developed with the view to reducing the adverse effects profile associated with non-selective inhibitors such as theophylline.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion evidence source_evidence_literature NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion SIO_000772 10730545 NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion wasDerivedFrom befree-20140225 NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion wasGeneratedBy ECO_0000203 NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- befree-20140225 importedOn "2014-02-25" NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.